Bonny Deal: Wyeth Acquires Scottish Drug Discovery Firm Haptogen
Firm hopes to use Haptogen’s technology to generate novel protein therapeutics that can be made orally bioavailable, VP-Biologic Technologies Projan tells “The Pink Sheet” DAILY.
Firm hopes to use Haptogen’s technology to generate novel protein therapeutics that can be made orally bioavailable, VP-Biologic Technologies Projan tells “The Pink Sheet” DAILY.